Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

598-CL-004

NCT ID:

NCT00050297

Start Date:

Completion Date:

February 2004

Related Keywords:

• Prostate Cancer
• Prostatic Neoplasms

Name	Location